Hemophilia | Rheumatoid arthritis | p-Value | |
---|---|---|---|
Number of knees (patients) | 48 (37) | 92 (63) | |
Hemophilia type A/Ba | 32/5 | ||
Hemophilia severity (severe/moderate)b | 4/33 | ||
HIV (negative/positive) | 37/0 | 63/0 | |
HBV (negative/positive) | 14/23 | 33/30 | 0.159 |
HCV (negative/positive) | 10/27 | 63/0 | < 0.001 |
Factor inhibitor (negative/positive) | 31/6 | ||
Age (years) | 46.7 ± 11.2 | 57.4 ± 10.1 | < 0.001 |
Female/male | 3/34 | 58/5 | < 0.001 |
Body mass index (kg/m2) | 22.4 ± 2.8 | 25.0 ± 4.0 | 0.011 |
Right/left | 26/22 | 49/43 | 0.919 |
Normal patellar height/patella baja | 34/14 | 87/5 | < 0.001 |
Operating period | 2002–2018 | 2003–2018 | |
CR/PS/CCKc | 1/46/1 | 9/80/3 | 0.321 |
PFC/Triathlon/Lospa/NexGen/Persona/Attuned | 12/24/9/0/2/1 | 56/1/1/13/12/9 | < 0.001 |
Surgical approach (MPPA/rectus snip/V–Y quadricepsplasty) | 44/1/3 | 92/0/0 | 0.013 |
Patella resurfacing/patella non-resurfacing | 46/2 | 86/6 | 0.715 |
Follow-up period (years) | 8.8 ± 4.9 | 8.0 ± 4.6 | 0.389 |